When was Freyr Solutions founded?

Freyr Solutions was founded in 2007.

Where is Freyr Solutions located?

Freyr Solutions is headquartered in Princeton, United States. It is registered at Princeton, New Jersey.

Who is the current CEO of Freyr Solutions?

Suren Dheenadayalan and Rajiv Rangan s of Freyr Solutions. Suren Dheenadayalan has also founded 1 company.

How many employees does Freyr Solutions have?

As of Jan 31, 2026, the latest employee count at Freyr Solutions is 2207.

Is Freyr Solutions a funded company?

Freyr Solutions is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Freyr Solutions rank among its competitors?

Freyr Solutions ranks 11th amongst 1025 active competitors, of which 64 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Ipsen, which secured $618K in Dec, 2023.

Who are the top competitors of Freyr Solutions?

Freyr Solutions' top competitors include Precision Medicine Group, WuXi AppTec and ANI Pharmaceuticals. Among them, Ipsen secured the most recent funding round in December, 2023.

Freyr Solutions - 2026 Company Profile, Team & Competitors

Company Details

Provider of regulatory services and solutions for biopharma, consumer healthcare and medical device companies. Its regulatory operations includes regulatory labeling and artwork, submissions and publishing, dossier management, strategy, safety, pharmacovigilance, and medical writing.

Website: www.freyrsolutions.com/
Social
Email ID: *****@freyrsolutions.com
Phone Number: +1 **********
Registered Address: Princeton, New Jersey

Key Metrics

Founded Year

2007

Location

Princeton, United States

Stage

Unfunded

Ranked

11^th among 1025 active competitors

Employee Count

2,207 as on Jan 31, 2026

Similar Companies

Precision Medicine Group & 1069 more

View Freyr Solutions' full profile

Freyr Solutions is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
GITE Solutions a.s. CIN: 04958438 , Czech Republic, Active	Apr 05, 2016	-	-
FREYR SOFTWARE SERVICES PRIVATE LIMITED CIN: U72200TG2013PTC085299 , India, Active	Jan 09, 2013	$32.5M (As on Mar 31, 2024)	1733 (As on Aug 31, 2025)
FREYR INC. CIN: 453812186 , United States, Active	Dec 26, 999	-	111 (As on Dec 31, 2024)	-

Freyr Solutions has not raised any funding rounds yet.

The founders of Freyr Solutions are Srini Sadhu, Suren Dheenadayalan and Rajiv Rangan. Suren Dheenadayalan and Rajiv Rangan are the CEOs of Freyr Solutions.

Here are the details of Freyr Solutions' key team members:

Srini Sadhu: Co-Founder of Freyr Solutions.
Contact Info: 1 email address
Suren Dheenadayalan: Founder & CEO of Freyr Solutions.
Contact Info: 1 email address
Rajiv Rangan: Co-Founder & Co-CEO of Freyr Solutions.

View details of Freyr Solutions's Founder profiles and Board Members

Freyr Solutions' employee count trend

Freyr Solutions has 2,207 employees as of Jan 26. Here is Freyr Solutions's employee count trend over the years:

Employee count trend for Freyr Solutions

Uncover Freyr Solutions' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Freyr Solutions include Precision Medicine Group, WuXi AppTec and ANI Pharmaceuticals. Here is the list of Top 10 competitors of Freyr Solutions, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Oak Investment Partners & 7 others	71/100
2nd	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	70/100
3rd	ANI Pharmaceuticals 1996, Baudette (United States), Public	Pharmaceutical company developing, manufacturing, and marketing high quality branded and generic prescription drugs	-	US Bank, Ampersand Capital & 4 others	63/100
4th	Aptar 1992, Crystal Lake (United States), Public	Provider of regulatory support, brand differentiation, and prototyping services	-	Al Zayani Investments	63/100
5th	Avania 1988, Brunswick (Australia), Acquired	Provider of regulatory, clinical trials and analytic services	-	Kester Capital, Omnes Capital & 1 others	63/100
6th	Red Nucleus 2014, Yardley (United States), Acquired	Provider of advisory, scientific and medical communications for pharmaceutical industry	-	Maranon Capital, Renovus Capital Partners	57/100
7th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, PAI Partners & 2 others	57/100
8th	CHEPLAPHARM 1998, Mesekenhagen (Germany), Late Stage	Pharmaceutical company that specializes in the development, marketing, and distribution of branded pharmaceutical products	$547M	GIC, Atlantic Park & 4 others	56/100
9th	Isolere Bio 2017, Durham (United States), Acquired	Developer of bioprocessing reagents for purification and manufacturing of therapeutics	$7M	Northpond Ventures, NCBiotech & 2 others	56/100
10th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	55/100
11th	Freyr Solutions 2007, Princeton (United States), Unfunded	Provider of regulatory services and solutions for biopharma, consumer healthcare and medical device companies	-	-	55/100